In the cohort analyzed (n¼1,028,125), the prevalence of epilepsy was 0.44% (n¼4,528). Overall, 55% (n¼2,508) received any of these AEDs during pregnancy, the most common of which were lamotrigine (49.8%) and levetiracetam (42.5%). Compared to the non-epileptic control group, women on AEDs showed significant increases in the absolute risk of cesarean delivery (5.0%), preeclampsia (0.7%), severe preeclampsia/eclampsia (0.9%) and SMM (1.6%). AEDs with the highest increases in absolute risk were topiramate (6.7%) for cesarean delivery, lamotrigine for pre-eclampsia (1.1%), and lacosamide for severe preeclampsia/eclampsia (8.4%) and SMM (9.3%). Of the 2,508 women, 414 (16.5%) received more than one AED during pregnancy. Compared to women receiving a single AED, those who received multiple AEDs had higher absolute risks of all outcomes except postpartum hemorrhage (Table) . CONCLUSION: Compared to non-epileptic women, women on newer generation AEDs demonstrated an increased absolute risk for cesarean delivery, preeclampsia, severe preeclampsia/eclampsia and severe maternal morbidity. Women receiving multiple medications demonstrated the highest increase in absolute risk for adverse outcomes, similar to findings in older AEDs, possibly also reflecting a more complicated and difficult disease state.
514 Postpartum readmission for hypertensive diseases of pregnancy after a delivery hospitalization without preeclampsia or hypertension OBJECTIVE: Hypertensive diseases of pregnancy (HDP) including preeclampsia and gestational hypertension are a leading cause of maternal morbidity and mortality. The disease course of HDP is unpredictable. Risk for postpartum readmission for HDP among women without HDP or chronic hypertension (cHTN) during delivery hospitalization is not well characterized. This analysis determined risk factors for HDP-associated readmissions among women without HDP or cHTN during delivery. STUDY DESIGN: We identified delivery hospitalizations from 2010-2014 using the Nationwide Readmissions Database, designed by the Healthcare Cost and Utilization Project using population weights to create national readmission estimates. We evaluated 60-day readmission temporality and risk for HDP after delivery hospitalization. Women were stratified by hypertensive status (HDP/cHTN vs. nonhypertensive) during delivery hospitalization. We created log-linear regression models adjusting for clinical and patient characteristics to analyze risk factors for readmission. Using Centers for Disease Control and Prevention criteria, risk for severe morbidity during readmission was evaluated. RESULTS: Of 14.1 million delivery hospitalizations from 2010-2014 without HDP or cHTN, 40,959 women (0.29%) were readmitted within 60 days with primary diagnosis of HDP. Factors strongly associated with readmission included older maternal age, lowest income quartile, multiple gestation, chronic kidney disease, and lupus (Table) . Over 90% of readmissions occurred within 20 days of discharge ( Figure) . Among women without prior HDP diagnosis, severe morbidity occurred in 13.6% of readmissions. Risk for severe morbidity among readmitted women with HDP or cHTN at delivery was significantly lower (6.5%, p<0.01). Women readmitted without prior HDP diagnosis were also at significantly higher risk for eclampsia (p<0.01). CONCLUSION: Women readmitted postpartum for HDP without a hypertension diagnosis at delivery are at high risk for severe morbidity both absolutely and compared to women with prior diagnoses of HDP and cHTN. Many of these readmissions occur soon after hospital discharge. Close post-discharge follow-up for at-risk women may be important to reduce readmission-associated maternal morbidity.
OBJECTIVE: Whether antepartum (AP) inpatient admissions for hypertensive diseases of pregnancy (HDP) are associated with increased risk for postpartum (PP) readmissions is not well characterized. The purpose of this study was to determine whether AP HDP admission is associated with 30-day PP HDP readmission rates. STUDY DESIGN: Delivery hospitalizations October and November of 2010 to 2014 were identified using the Nationwide Readmissions Database, a nationally representative discharge database. We identified AP admissions with the primary diagnosis of HDP occurring within 9 months preceding delivery and PP readmissions within 30 days of discharge from delivery. The primary outcome was 30-day HDP readmission. Risk for severe maternal morbidity (SMM) was also analyzed based on CDC criteria. AP admission length of stay of (aLOS) and number of antepartum admissions were also analyzed as risk factors for readmission. Adjusted log linear regression models were used to analyze risk for readmission and morbidity with risk ratios (RR) and 95% confidence intervals (CI) as the measures of effect. RESULTS: 3.1 million deliveries were analyzed with 11,393 (0.4%) antepartum admissions and 8,964 (0.3%) postpartum readmissions. Of the women admitted AP, 92% were admitted only once with median aLOS 1.6 days. AP admission was associated with higher risks of 30-day PP HDP readmission (2.4% vs. 0.3%, p<0.01). In adjusted analysis controlling for the presence of HDP at delivery, patients with an antepartum HDP admission were at 65% higher risk of 30-day postpartum readmission (RR 1.65, 95% CI 1.45, 1.87) ( Table 1) . Risk for SMM was not significantly increased. Patients who had more than one AP admission further increased risk for readmission. In comparison, aLOS > 7d was significantly associate with a 50% decreased risk for PP HDP readmission (RR¼0.50, 95% CI: 0.27, 0.92, p<0.01) ( Table 2) . CONCLUSION: AP HDP admission is a risk factor for readmission independent of HDP status at delivery. However, AP admission was not associated with SMM at readmission and increased aLOS was associated with decreased readmission risk. Longer surveillance of patients in the hospital may result in more detailed management plans that subsequently facilitate outpatient management. For patients with AP admissions close interval follow up after delivery discharge may be indicated. OBJECTIVE: Preeclampsia (PE) is a disease of incompletely understood etiology that is the leading contributor to iatrogenic preterm birth (PTB). Our objective was to identify if PE in dichorionic pregnancies is characterized by similarities or dissimilarities in the transcriptome profile of the two placentas. STUDY DESIGN: Total RNA was extracted from 60 placental villous tissue samples and subjected to RNA-seq using the Illumina platform. Our study was designed to include two analytical stages: In the first stage placental samples (n¼18) originated from singleton pregnancies with unambiguous clinical phenotypes: 1) severe features early-onset PE (sPE, n¼8, GA: 30AE1 wks); 2) idiopathic preterm birth (n¼5, GA: 32AE1wks) and 3) term non-labor (n¼5, GA: 39AE1wks). These samples were used to extract a generic transcriptomic signature of PE placenta. In the second stage placentas of 16 twin pregnancies classified based on chorionicity and PE diagnosis were included as follows: di-di nonPE (n¼7, GA: 32AE1 wks), mono-di nonPE (n¼2, GA: 32AE1 wks), di-di PE (n¼5, GA: 33AE2 wks) and mono-di PE (n¼2, GA: 33AE3 wks). Two separate biopsies were sequenced from monochorionic placentas. An additional set of singleton PE placentas (n¼10, GA: 33AE1 wks) was sequenced interspaced among the twin placentas to control for batch effects. Principal components analysis (PCA) and statistical modeling for similarity and dissimilarity between sibling placentas were applied. RESULTS: Our first stage analysis extracted a subset of 613 transcripts differentially expressed between sPE and non-PE singleton placentas. This molecular classifier showed linear separability among first stage samples independent of GA at birth. When applied to twin gestation placentas the classifier revealed several characteristics: 1) In the non-PE cases, biopsies from monochorionic placentas had more similar expression patterns of the genes composing the PE signature than dichorionic placentas which were more scattered in the PCA space (Fig. A) ; 2) Monochorionic nonPE placentas have closer proximity to the PE space compared to singleton nonPE placentas; 3) Dichorionic sibling placentas of pregnancies complicated by PE were the most discordant (Fig. B) . CONCLUSION: In dichorionic pregnancies complicated by PE, the disease affects each placenta individually. Conversely, PE in twins could be the result of a single diseased placenta.
517 Dosing of labetalol in obese preeclamptic women with severe antepartum hypertension Yiwen Cui, Ethan A. Litman, Paul Feustal, Johanna Bringley, Asha Rijhsinghani Albany Medical Center, Albany, NY OBJECTIVE: To determine the impact of pre-existing chronic hypertension and maternal obesity on the response to intravenous (IV) labetalol in acute control of severe antepartum hypertension. STUDY DESIGN: We examined a retrospective cohort of all patients in our institution who received IV labetalol for acute management of severe hypertension during peripartum admission between June
